Our study unveils a notable disparity in PRL thresholds between genders: (i) females exhibit lower thresholds for adenoma invasiveness compared to males, demonstrating consistent performance across various age and obesity categories. The gene discussed is PRL; the disease is obesity due to melanocortin 4 receptor deficiency.